All posts tagged "Tildrakizumab"
-
1.5KHealth BusinessSun Pharma signs $55.5 m deal for anti- psoriasis drug
Sun Pharmaceutical Industries Ltd and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun...
- 909News
Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:...
- 1.1KNews
Sun Pharma To Present Data from Tildrakizumab Clinical Development Program at the 2017 AAD Meeting
Sun Pharmaceutical Industries Ltd today announced that several new analyses from Phase-1 and the pivotal Phase-3 clinical trials (reSURFACE 1 and 2)...
